• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by AdaptHealth Corp.

    7/2/26 4:01:45 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care
    Get the next $AHCO alert in real time by email
    AdaptHealth Corp._June 27, 2026
    0001725255false00017252552026-06-272026-06-27

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    ​

    FORM 8-K

    ​

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d)

    of The Securities Exchange Act of 1934

    ​

    Date of Report (Date of earliest event reported): June 27, 2026

    AdaptHealth Corp.

    (Exact name of registrant as specified in its charter)

    ​

    Delaware

      ​ ​ ​

    001-38399

      ​ ​ ​

    82-3677704

    (State or other jurisdiction of
    incorporation)

     

    (Commission File Number)

     

    (IRS Employer Identification No.)

    ​

    ​

    ​

    555 East North Lane, Suite 5075

    Conshohocken, PA

      ​ ​ ​

    19428

    (Address of principal executive offices)

     

    (Zip Code)

     

     

     

    (610) 424-4515

    (Registrant’s telephone number, including area code)

    ​

    Not Applicable

    (Former name or former address, if changed since last report.)

    ​

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ​

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    ​

    Securities registered pursuant to Section 12(b) of the Act:

    ​

    Title of each class

      ​ ​ ​

    Trading
    Symbol(s)

      ​ ​ ​

    Name of each exchange on which
    registered

    Common Stock, par value $0.0001 per share 

     

    AHCO 

     

    The Nasdaq Stock Market LLC

    ​

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    ​

    Emerging growth company ☐

    ​

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

    ​

    ​

    ​

    Item 1.05 Material Cybersecurity Incidents.

    AdaptHealth Corp. (the “Company”) is investigating a security incident whereby a threat actor gained unauthorized access to Company systems and exfiltrated certain data therefrom. Upon learning of the incident, the Company promptly activated its incident response procedures, launched the investigation with the support of external advisors and cybersecurity experts to assess and contain the threat and notified law enforcement. While the investigation is ongoing, the Company has been able to confirm certain facts about the incident, and on June 27, 2026, the Company determined that the incident is material, due to the nature and potential volume of the data that is at risk.

    Specifically, based on information obtained to date, the Company believes that a threat actor gained unauthorized access to certain of the Company’s cloud-based business applications, including certain internal patient management systems and document storage platforms. On June 15, 2026, the Company received a communication from a threat actor claiming to have obtained certain data from the Company’s systems. The Company has confirmed that certain data was exfiltrated from its systems including a stored password file associated with insurance billing; the Company also has confirmed that certain external electronic health record system portals were accessed by the threat actor.

    The data affected includes passwords associated with insurance billing and certain personally identifiable information and protected health information of patients. The Company does not collect Social Security numbers in the affected systems and does not store individual financial account information or payment card information in those systems.

    The incident was the result of a successful social engineering attack that compromised a user session associated with a third-party contractor. Following detection, the Company promptly implemented containment measures, including disabling the compromised user account, resetting affected credentials, and implementing additional access controls, and the incident has been contained. The Company is continuing to investigate the nature and scope of the incident with external forensics teams. The full scope of affected data sets has not yet been determined, and specific information regarding the volume of data at issue is not yet available. The Company has since taken steps intended to mitigate the risk of dissemination of the exfiltrated data.

    As of the date of this Report, the incident has not had a material impact on the Company’s operations and has not affected the Company’s ability to service its patients. At this time, the Company is unable to determine the full financial impact of the incident, including remediation and response costs, legal, regulatory and notification-related matters, and possible effects on patients, counterparties and the Company’s reputation. The Company maintains cybersecurity insurance that may cover certain losses associated with the incident.

    To the extent any information required by Item 1.05 of Form 8-K was not determined or was unavailable at the time of this filing, the Company will amend this Current Report on Form 8-K as such information is determined or becomes available.

    Forward-Looking Statements

    This Current Report on Form 8-K contains statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. The forward-looking statements include, but are not limited to, statements regarding the Company’s current beliefs, understanding, and expectations regarding the incident; statements regarding the nature and scope of the incident; the Company’s ongoing assessment of the extent, categories and volume of data that was accessed or exfiltrated; the Company’s ongoing efforts to assess and contain the threat, including the Company’s assessment of whether there is any ongoing unauthorized access to its systems; the availability and adequacy of the Company’s insurance coverage; and the potential impact of the incident on the Company’s business, operations, financial condition and results of operations. These statements are based on current information, estimates and assumptions and are subject to known and unknown risks and uncertainties. Actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ from those expressed in these forward-looking statements include the ongoing assessment of the incident; the inability to determine the full scope of affected data sets and volume of data involved; the potential publication or misuse of affected data by the threat actor or other parties; legal, regulatory, reputational, and financial risks resulting from the incident or additional cybersecurity incidents; and the risks described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent Quarterly Reports on Form 10-Q. Except as required by law, the Company undertakes no obligation to update these statements.

    ​

    ​

    - 2 -

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Dated: July 2, 2026

    AdaptHealth Corp.

    By:

    /s/ Richard Rew

    ​

     

    Name:

    Richard Rew

    ​

     

    Title:

    Chief Legal Officer, General Counsel and Secretary

    ​

    ​

    ​

    ​

    ​

    - 3 -

    Get the next $AHCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHCO

    DatePrice TargetRatingAnalyst
    1/8/2024$14.50 → $8.00Buy → Hold
    Jefferies
    11/8/2023$9.50 → $6.50Neutral → Underperform
    BofA Securities
    5/10/2023$28.00 → $11.30Buy → Hold
    Deutsche Bank
    5/10/2023$18.00 → $11.00Buy → Hold
    Stifel
    5/9/2023$21.00 → $12.00Buy → Neutral
    BofA Securities
    3/8/2022$31.00 → $26.00Outperform
    RBC Capital
    3/2/2022$32.00 → $24.00Outperform
    SVB Leerink
    2/18/2022$35.00 → $32.00Outperform
    SVB Leerink
    More analyst ratings

    $AHCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Cashin Richard M Jr bought $19,912,148 worth of shares (2,046,691 units at $9.73) (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    3/12/26 9:11:41 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Wolf Dale B bought $71,680 worth of shares (8,000 units at $8.96), increasing direct ownership by 8% to 104,235 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    3/3/26 6:41:28 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    CLO and General Counsel Rew Richard W. Ii bought $44,550 worth of shares (5,000 units at $8.91), increasing direct ownership by 5% to 107,097 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    2/27/26 4:01:18 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Commercial Officer Schuster Iii Russell E. sold $117,711 worth of shares (11,275 units at $10.44) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 125,263 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    7/6/26 4:01:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Williams David Solomon Iii was granted 18,999 shares, increasing direct ownership by 42% to 64,044 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    6/26/26 4:20:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Weaver Susan T was granted 18,999 shares, increasing direct ownership by 89% to 40,345 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    6/26/26 4:17:17 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardinal Health expands home care business with two tuck-in acquisitions

    DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments."These strategic transactions build on the synergies created by our recent investments in home care," said Jason Hollar, Chief Executive Officer, C

    7/20/26 4:45:00 PM ET
    $CAH
    $AHCO
    Other Pharmaceuticals
    Health Care
    Medical/Nursing Services

    AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health

    Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businesses Sharpens strategic focus on businesses where the Company crosses the threshold of the home to deliver clinical value to patients Increases capital flexibility for reinvestment in core businesses and debt reduction, accelerating AdaptHealth's deleveraging trajectory and strengthening its balance sheet Improves AdaptHealth's expected revenue growth profile and adjusted EBITDA margins on a go-forward basis Positions Diabetes Health with an owner whose scale and operational capabilities are matched to the demands of direct-to-patient dist

    7/20/26 4:30:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2026 financial results before the opening of the financial markets on Tuesday, August 4, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 274-8461 (Domestic) or (203) 518-9814 (International) When prompted, reference Conference ID: AHCO2Q26 Webcast registration: Click Here Followin

    7/14/26 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    SEC Filings

    View All

    AdaptHealth Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    7/20/26 4:35:23 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    7/7/26 4:45:49 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form 8-K filed by AdaptHealth Corp.

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    7/2/26 4:01:45 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AdaptHealth downgraded by Jefferies with a new price target

    Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously

    1/8/24 9:03:40 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth downgraded by BofA Securities with a new price target

    BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously

    11/8/23 6:22:25 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously

    5/10/23 6:33:54 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/14/24 9:03:31 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by AdaptHealth Corp.

    SC 13G - AdaptHealth Corp. (0001725255) (Subject)

    11/13/24 9:30:46 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/12/24 1:30:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $AHCO
    Leadership Updates

    Live Leadership Updates

    View All

    AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye

    12/3/24 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Appoints Diana Nole to Board of Directors

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B

    10/17/24 8:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

    Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served

    9/25/24 11:19:00 AM ET
    $AHCO
    $LH
    Medical/Nursing Services
    Health Care
    Medical Specialities

    $AHCO
    Financials

    Live finance-specific insights

    View All

    AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2026 financial results before the opening of the financial markets on Tuesday, August 4, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 274-8461 (Domestic) or (203) 518-9814 (International) When prompted, reference Conference ID: AHCO2Q26 Webcast registration: Click Here Followin

    7/14/26 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces First Quarter 2026 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2026. First Quarter Business Highlights Completed the largest de novo expansion in the history of the home medical equipment industry, meeting an aggressive go live schedule to become the exclusive provider to the more than 10 million members of our new strategic partner. The acceleration of the transition came with $12 million of elevated labor expense, of which the majority was variable and is ex

    5/5/26 7:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. Announces First Quarter 2026 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2026 financial results before the opening of the financial markets on Tuesday, May 5, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (833) 316-2483 (Domestic) or (785) 838-9284 (International) When prompted, reference Conference ID: AHCO1Q26 Webcast registration: Click Here Following th

    4/14/26 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care